SBI Life Insurance announced the outcome of its Board Meeting held on October 27, 2026. The board approved the unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, shareholders’ approval will be sought via postal ballot for the appointment of Mr. Nihar Niranjan Jambusaria as an Independent Director. The trading window for securities is set to reopen on October 30, 2026.
SBI Life Insurance Board Meeting Outcome
The Board of Directors of SBI Life Insurance convened on October 27, 2026, to review and approve key corporate actions. The meeting, which commenced at 03:30 P.M. and concluded at 06:45 P.M., focused on approving the unaudited financial results for the second quarter and the first half of the financial year ending September 30, 2026. The financial statements and limited review reports from joint statutory auditors M/s. K S Aiyar & Co. and M/s. J Singh & Associates have been finalized and are part of the disclosure.
Trading Window Re-opens
Following the disclosure of the financial results, SBI Life Insurance announced that the trading window for dealing in the company’s securities will be re-opened from Friday, October 30, 2026. This re-opening applies to all designated persons of the company, signifying a return to normal trading activities after a period of closure.
Appointment of Independent Director
In another significant decision, the Board agreed to seek shareholders’ approval for the appointment of Mr. Nihar Niranjan Jambusaria (DIN: 01808733) as an Independent Director. The process for obtaining this approval will involve a postal ballot. The Notice of Postal Ballot is scheduled to be circulated on Tuesday, November 03, 2026, through electronic mode. The e-voting period will commence on Wednesday, November 04, 2026, at 09:00 A.M. IST and conclude on Thursday, December 03, 2026, at 05:00 P.M. IST.
Source: BSE
